Fifty 410 review
Fifty 410 is a direct-to-consumer weight-loss telehealth service offering personalized compounded semaglutide and tirzepatide prescribed by licensed providers and prepared by FDA-registered 503A and 503B…
Regulatory notice
FDA issued Aspen Aesthetics dba Fifty 410 a warning letter in February 2026. You can read it in FDA's warning-letter database. We still list Fifty 410, and we may earn a commission if you start care through the link on this page.
- Scores never bought
- 537 providers tracked
- Every factor auditable
- Updated August 2026
Semaglutide here is $199/mo — almost exactly our category median of $199.
- Semaglutide
- $199/mo
- Tirzepatide
- $133/mo (starting dose, compounded)
- Coverage
- Coverage not published
- Brand-name
- Compounded only
- Oral option
- Injectable only
- Verification
- Not independently listed
Best for: Budget-focused buyers wanting transparent no-membership compounded GLP-1 pricing.
MatchScript's take: Our #334 pick of 537 — priced at or below the category median.
The factor breakdown
Fifty 410 on the six Match Score factors — the same sub-scores the quiz reweights to your priorities. See the methodology.
Semaglutide from $199/mo puts Budget Fit at a below-par 55 — above the budget tiers.
Limited or undisclosed state coverage can slow your start, for a below-par 60 on Speed to Start.
Fifty 410 sticks to compounded injectables, for a below-par 66 on Formulary Match.
Support lands at a below-par 73 — lighter, meds-first support.
Flexibility scores a below-par 37 — fewer levers to flex your plan.
Thinner public disclosure than the top of the ranking keeps Transparency at a below-par 72.
Pricing in context
How Fifty 410's monthly price sits against the category median and the cheapest provider we track.
What we like
- Transparent public pricing from 99 dollars per month for semaglutide
- No membership or subscription; pay only for what you need
- Compounded by FDA-registered 503A and 503B pharmacies
- Fast 24 to 48 hour provider review
- Free one to two day shipping
The caveats
- Does not bill insurance directly
- Compounded GLP-1 is not an FDA-approved finished drug
- Specific clinician credentials are not publicly disclosed
- Served-states list is not published on the site
- FDA issued Aspen Aesthetics dba Fifty 410 a warning letter in February 2026; the letter is public in FDA's warning-letter database
Who it's for — and who should skip it
Fifty 410 is for budget-focused buyers wanting transparent no-membership compounded GLP-1 pricing.
Skip it if that doesn't sound like you. A closer fit may be MEDGm (Match Score 60) — or take the quiz to see where Fifty 410 lands for your priorities.
How it compares to CoreAge Rx & the closest scorer
Fifty 410 against our #1 overall pick and the provider that scores closest to it. Green marks the row leader.
| How it compares | Fifty 410this provider | CoreAge Rxour #1 | MEDGmclosest scorer |
|---|---|---|---|
| Sema price | $199/mo | $99/mo at every dose | $299/mo |
| Coverage | Coverage not published | All 50 states | All 50 states plus Washington, D.C. |
| Formulary | Injectable | Injectable | Injectable + oral |
| Match Score | 60 · C | 91 · A− | 60 · C |
Fifty 410, answered
Is Fifty 410 legit?
Fifty 410 is a real, operating GLP-1 telehealth program. LegitScript certification is the third-party check worth asking for — look for the seal on their site and confirm your prescriber is US-licensed at intake. Like most programs here it dispenses compounded GLP-1s, which are made by a licensed pharmacy but aren't FDA-approved.
How much does Fifty 410 cost?
Fifty 410 lists compounded semaglutide from $199/mo and tirzepatide from $133/mo (starting dose, compounded) — right at our category median. These are the provider's public figures at our last review (August 2026); confirm on their site, since some teaser tiers step up after month one.
Does Fifty 410 ship to my state?
Fifty 410 doesn't publish a full state list, so confirm your state is covered during intake before you pay.
Fifty 410 vs MEDGm — which should I pick?
They score within a few points of each other: Fifty 410 at 60/100 and MEDGm at 60/100, so neither wins on the headline number. Fifty 410 is the better fit for budget-focused buyers wanting transparent no-membership compounded GLP-1 pricing. MEDGm suits people who want four named pharmacies and a fifty-state footprint, and who will click the coupon off before deciding what the program costs. Run the quiz and the weighting shifts to whichever of those matters more to you.
Pricing & state data last verified August 2026 from Fifty 410's public site and our master provider matrix. The Match Score and its sub-scores are our editorial judgment per the methodology. Commercial facts only — prices change, so confirm on Fifty 410's site. Not medical advice; see our disclosure.
Semaglutide here is $199/mo — almost exactly our category median of $199. Tirzepatide is $133/mo (starting dose, compounded). It scores highest on the care that comes after the first vial. Best suited to budget-focused buyers wanting transparent no-membership compounded GLP-1 pricing. If that is not you, MEDGm is the closest thing to it here.
Compare with other providers
Our next-best picks in default ranking order, then the 24 programs that sit nearest Fifty 410 here.
- #1Match91/ 100CoreAge RxThe best all-around match: nationwide access, both molecules at one flat, no-surprise price, and an easy exit.91/100
- #2Match84/ 100Strut HealthThe only program here carrying both LegitScript and ACHC accreditation, with an oral lozenge route on both molecules at the cheapest entry in this ranking.84/100
- #3Match83/ 100EdenA polished, high-disclosure compounded program with strong nationwide coverage and hands-on support.83/100
- #4Match85/ 100RoA heavyweight telehealth brand with brand-name access and a polished experience — but opaque compounded pricing.85/100
- #5Match85/ 100No BS RXThe highest Transparency score here, and it is not close: twenty-four prices on one public page and four dispensing pharmacies named with street addresses.85/100
Compare 24 nearby providersHide them
| Provider | Tirzepatide price | Coverage | Alternatives | Go | ||
|---|---|---|---|---|---|---|
| Ivim Health#335 | 60 | $268/mo | $355/mo | Coverage not published | Alternatives | Visit |
| TeleHealth Med#336 | 60 | $263/mo | Not disclosed | Coverage not published | Alternatives | Visit |
| June Health#337 | 60 | $283/mo | $202/mo | Coverage not published | Alternatives | Visit |
| Neo Soma Healthcare#338 | 60 | $216/mo | $239/mo | Coverage not published | Alternatives | Visit |
| Pomegranate Health#339 | 60 | $129/mo | $149/mo (Starter plan, dose not published, compounded) | Coverage not published | Alternatives | Visit |
| Premium Health#340 FDA issued Premium Health Management Inc. dba Premium Health a warning letter in February 2026. See FDA's warning-letter database. | 60 | $275/mo (all doses, compounded) | $445/mo (all doses, compounded) | Coverage not published | Alternatives | Visit |
| WeightCare#341 FDA issued Weightless Medical LLC dba WeightCare a warning letter in February 2026. See FDA's warning-letter database. | 60 | $399/mo | $499/mo (15 mg dose, compounded) | Coverage not published | Alternatives | Visit |
| 9amHealth#342 | 60 | $149/mo (plus a separate fee, brand-name) | Not disclosed | Coverage not published | Alternatives | Visit |
| Aurelius Health Group#343 | 60 | Not disclosed | $199/mo (microdose tier, compounded) | Coverage not published | Alternatives | Visit |
| CVS MinuteClinic#344 | 60 | Not disclosed | Not disclosed | Coverage not published | Alternatives | Visit |
| Genesis Health#345 FDA issued Genesis Health International Inc. dba Genesis a warning letter in February 2026. See FDA's warning-letter database. | 60 | $178/mo | $228/mo | Coverage not published | Alternatives | Visit |
| PrideRx#346 | 60 | $149/mo (starting dose, plus a separate fee, brand-name) | $299/mo (2.5 mg dose, plus a separate fee, brand-name) | Coverage not published | Alternatives | Visit |
| Oxford's Medical Weight Loss (The Calibrate Clinic)#347 | 60 | $218/mo | $334/mo | 2 states | Alternatives | Visit |
| Vitalex Health#348 | 60 | $199/mo (starting dose, compounded) | $199/mo (starting dose, compounded) | Coverage not published | Alternatives | Visit |
| Harmony Wellness Clinic#349 | 60 | $203/mo | $254/mo | 36 states | Alternatives | Visit |
| Lumora#350 | 60 | $249/mo | $330/mo | Coverage not published | Alternatives | Visit |
| Obu Health#351 | 60 | $193/mo | $242/mo | Coverage not published | Alternatives | Visit |
| Revive Meds#352 | 60 | $374/mo | $466/mo | All 50 states | Alternatives | Visit |
| Intimate Rose#353 FDA issued Intimate Rose a warning letter in September 2025. See FDA's warning-letter database. | 59 | $303/mo | $405/mo | Coverage not published | Alternatives | Visit |
| MediRX#354 | 59 | $253/mo | $399/mo | Coverage not published | Alternatives | Visit |
| PauseRX#355 | 59 | $202/mo | $253/mo | Coverage not published | Alternatives | Visit |
| Center for Medical Weight Loss (CMWL)#356 | 59 | $162/mo | $260/mo | Coverage not published | Alternatives | Visit |
| Woodwork#357 | 59 | $155/mo | $228/mo | Coverage not published | Alternatives | Visit |
| Alegro Health#358 | 59 | $199/mo (starting dose, compounded) | Not disclosed | Coverage not published | Alternatives | Visit |
Fifty 410 is ranked on our best semaglutide providers, best tirzepatide providers and best GLP-1 programs boards, scored on the same six factors as every other provider there.